Haleos Labs Ltd
Tue 13/01/2026,9:44:1 | NSE : HALEOSLABS
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 0.00
Previous Close
₹ 1299.00
Volume
0
Mkt Cap ( Rs. Cr)
₹392.72
High
₹ 0.00
Low
₹ 0.00
52 Week High
₹ 1680.00
52 Week Low
₹ 959.80
Book Value Per Share
₹ 682.76
Dividend Yield
0.11
Face Value
₹ 10.00
What’s Your Call?
Collective community sentiment on Haleos Labs Ltd
Your Vote -
Buy
38.64%
Hold
11.36%
Sell
50.00%
38.64%
44 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
NaN%
Sell Order Quantity
NaN%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Haleos Labs Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Haleos Labs has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025
-
Haleos Labs - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Haleos Labs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Haleos Labs - Trading Window
-
Haleos Labs - Updates
-
Haleos Labs - Report (Special Window)
-
Haleos Labs - Disclosure of material issue
-
Haleos Labs - Demand Notice
-
Haleos Labs - Updates
-
Haleos Labs - Name Change
-
Haleos Labs - New Logo
-
Haleos Labs - New Scrip ID (HALEOSLABS)
-
SMS Lifesciences Ind - Name and Symbol Change
-
SMS Lifesciences Ind - Copy of Newspaper Publication
-
SMS Lifesciences Ind - Newspaper Publication (Financial Results)
-
SMS Lifesciences Ind Q2 net profit down 17.14% at Rs 4.98 cr
-
SMS Lifesciences Ind - Outcome of Board Meeting
-
SMS Lifesciences Ind - Board Meeting Outcome for For The Meeting Held On November 10, 2025
-
SMS Lifesciences Ind - Updates
-
SMS Lifesciences Ind - Temporary Withholding Of Dividend
-
SMS Lifesciences Ind - Updates
-
SMS Lifesciences Ind - Report (Special Window)
-
SMS Lifesciences Ind - Board Meeting Intimation for 95Th Board Meeting (10.11.2025)
-
SMS Lifesciences Ind has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025
-
SMS Lifesciences Ind - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
SMS Lifesciences Ind - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
SMS Pharma receives non-exclusive license to manufacture & supply Molnupiravir
Key fundamentals
Evaluate the intrinsic value of Haleos Labs Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 276.348 | 264.957 | 249.1726 | 210.9553 | 168.1632 |
| Liabilities | 276.348 | 264.957 | 249.1726 | 210.9553 | 168.1632 |
| Equity | 3.0233 | 3.0233 | 3.0233 | 3.0233 | 3.0233 |
| Gross Profit | 44.2317 | 34.4313 | 26.4065 | 31.3647 | 29.7351 |
| Net Profit | 21.3708 | 13.0654 | 13.2176 | 25.3813 | 13.1683 |
| Cash From Operating Activities | 28.0325 | 14.7514 | 4.5753 | -14.6554 | 21.6184 |
| NPM(%) | 6.41 | 4.35 | 4.19 | 7.34 | 5.05 |
| Revenue | 333.371 | 300.0016 | 315.2418 | 345.6281 | 260.2555 |
| Expenses | 289.1393 | 265.5703 | 288.8353 | 314.2634 | 230.5204 |
| ROE(%) | 10.35 | 6.32 | 6.4 | 12.29 | 6.37 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|---|---|---|---|
| 1.5 | 15 | 0.12 | 1373.4 | |
| 23 Sep 2024 | 1.5 | 15 | 0.12 | 696.3 |
| 22 Sep 2022 | 1.5 | 15 | 0.12 | 637.6 |
| 20 Sep 2021 | 1.5 | 15 | 0.12 | 659.8 |
| 19 Sep 2019 | 1.5 | 15 | 0.12 | 483.4 |
Peers
Other companies within the same industry or sector that are comparable to Haleos Labs Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 738.60 | 1.32 | 0.00 | 719.11 | 301.39 | 0.68 |
| Lotus Eye Hospital and Institute Ltd | 110.47 | 0.29 | 345.22 | 2620.33 | 3.55 | 0.00 |
| Vaishali Pharma Ltd | 8.63 | -0.58 | 0.00 | 16438.23 | 3.13 | 0.00 |
| Astec Lifesciences Ltd | 628.70 | -1.43 | 0.00 | 2471.04 | -604.77 | 0.00 |
Company Info
SMS Lifesciences India Limited incorporated under the provisions of the Companies Act, 1956, on 31st day of May, 2006, originally as Private Limited Company in the name of "Potluri Real Estate Private Limited" and subsequently changed its name to "Potluri Packaging Industries Private Limited" on 6th November, 2013. Thereafter the Company had changed its name as "SMS Lifesciences India Private Limited" on 4th August, 2014 and subsequently converted as Public Limited Company with effect from 22nd June, 2016 and its Corporate Identity No. is U74930TG2006PLC050223. The Company is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, Active Pharmaceutical Ingredients (API) and Intermediates. 2020 -Company has received the prestigious award in the 5th edition of India Pharma and Medical Device 2020.
SMS Lifesciences India Limited incorporated under the provisions of the Companies Act, 1956, on 31st day of May, 2006, originally as Private Limited Company in the name of "Potluri Real Estate Private Limited" and subsequently changed its name to "Potluri Packaging Industries Private Limited" on 6th November, 2013. Thereafter the Company had changed its name as "SMS Lifesciences India Private Limited" on 4th August, 2014 and subsequently converted as Public Limited Company with effect from 22nd June, 2016 and its Corporate Identity No. is U74930TG2006PLC050223. The Company is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, Active Pharmaceutical Ingredients (API) and Intermediates. 2020 -Company has received the prestigious award in the 5th edition of India Pharma and Medical Device 2020.
Read More
Parent Organisation
Haleos Labs Ltd.
Founded
31/05/2006
Managing Director
Mr.TVVSN Murthy
NSE Symbol
HALEOSLABSBE
FAQ
The current price of Haleos Labs Ltd is ₹ 1299.00.
The 52-week high for Haleos Labs Ltd is ₹ 0.00 and the 52-week low is ₹ 0.00.
The market capitalization of Haleos Labs Ltd is currently ₹ 392.72. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Haleos Labs Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Haleos Labs Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Haleos Labs Ltd shares.
The CEO of Haleos Labs Ltd is Mr.TVVSN Murthy, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
